Skip to main content

and
  1. No Access

    Article

    The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC)

    This study assessed current practice and methods for improvement in the management of families with hereditary non-polyposis colorectal cancer (HNPCC). HNPCC families registered at five London Genetics Centres...

    Johanne Geary, Huw J. W. Thomas, James Mackay, Huw Dorkins in Familial Cancer (2007)

  2. No Access

    Article

    L.A. Cannizzaro and K.H. Ramesh: Cancer genomics

    Julian Barwell in Human Genetics (2008)

  3. No Access

    Article

    Germline mutations in RAD51D confer susceptibility to ovarian cancer

    Nazneen Rahman and colleagues show that germline inactivating mutations in RAD51D confer susceptibility to ovarian cancer. They further show that RAD51D-deficient cells are sensitive to PARP inhibition, suggestin...

    Chey Loveday, Clare Turnbull, Emma Ramsay, Deborah Hughes, Elise Ruark in Nature Genetics (2011)

  4. No Access

    Article

    Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig Bojesen, Georgia Chenevix-Trench, Alison Dunning and colleagues report common variants at the TERT-CLPTM1L locus associated with mean telomere length measured in whole blood. They also identify associations ...

    Stig E Bojesen, Karen A Pooley, Sharon E Johnatty, Jonathan Beesley in Nature Genetics (2013)

  5. No Access

    Article

    Supporting families with Cancer: A patient centred survivorship model of care

    In 2011, the Leicestershire Clinical Genetics Department in collaboration with Macmillan Cancer Support initiated a project called Supporting Families with Cancer (SFWC). The project aimed to raise awareness ...

    Emily Victoria Craft, Caron Billington, Rory O’Sullivan, Wendy Watson in Familial Cancer (2015)

  6. Article

    Open Access

    Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls

    In the United Kingdom, current screening guidelines for TP53 germline mutation carriers solely recommends annual breast MRI, despite the wide spectrum of malignancies typically seen in this group. This study soug...

    Sibel Saya, Emma Killick, Sarah Thomas, Natalie Taylor in Familial Cancer (2017)

  7. No Access

    Article

    Inclusion of diverse populations in genomic research and health services: Genomix workshop report

    Clinical genetic services and genomic research are rapidly develo** but, historically, those with the greatest need are the least to benefit from these advances. This encompasses low-income communities, incl...

    Savio S. Mathew, Julian Barwell, Nasaim Khan, Ella Lynch in Journal of Community Genetics (2017)

  8. Article

    Open Access

    The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, whic...

    Gisella Figlioli, Massimo Bogliolo, Irene Catucci, Laura Caleca in npj Breast Cancer (2019)

  9. Article

    Open Access

    Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective

    The aim of this study was to assess the prevalence of germline variants in cancer-predisposing genes by either targeted (BRCA1/2) or multigene NGS panel in a high-risk Hereditary Breast and Ovarian Cancer (HBOC) ...

    María Molina-Zayas, Carmen Garrido-Navas in Molecular Genetics and Genomics (2022)